News Posted on March 27, 2023 AstraZeneca stays on course to challenge Alnylam with 66-week … – FierceBiotech AstraZeneca stays on course to challenge Alnylam with 66-week … FierceBiotech Source: AstraZeneca stays on course to challenge Alnylam with 66-week … – FierceBiotech By sf-admin